SLC5A7: Choline Transporter, High-Affinity

Solute Carrier Family 5 Member 7 – Key Regulator of Cholinergic Neurotransmission

Gene Information Card

Symbol SLC5A7
Full Name Solute Carrier Family 5 Member 7
Gene Type Protein coding
Chromosomal Location 2q12.3
NCBI Gene ID 60482 ncbi.nlm.nih.gov/gene/60482
Ensembl ID ENSG00000115665
UniProt ID Q9GZV3
OMIM ID 608761
HGNC ID 14025
Aliases CHT, CHT1, hCHT, MGC126852

Description

SLC5A7 encodes the high-affinity choline transporter 1 (CHT1), a sodium- and chloride-dependent transmembrane protein that mediates the rate-limiting step in acetylcholine synthesis: the reuptake of choline into presynaptic cholinergic neurons. CHT1 is predominantly expressed in the central and peripheral nervous systems and is critical for cholinergic neurotransmission. Mutations in SLC5A7 are associated with presynaptic congenital myasthenic syndrome and distal hereditary motor neuronopathy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital Myasthenic Syndrome 20 (CMS20) Loss-of-function mutations impair choline reuptake, reducing acetylcholine synthesis and causing neuromuscular junction dysfunction. ClinVar, OMIM #617143
Distal Spinal Muscular Atrophy, Autosomal Recessive (DSMA3) Biallelic mutations lead to progressive motor neuron degeneration due to cholinergic deficit. OMIM #617184
Amyotrophic Lateral Sclerosis (ALS) susceptibility Rare variants may contribute to motor neuron vulnerability, though evidence is limited. ClinVar, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Spinal cord 12.5 High
Brain (cerebellum) 8.2 Medium
Brain (cortex) 7.1 Medium
Placenta 0.3 Low
Liver 0.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.3 High expression; used for cholinergic studies
SK-N-SH (neuroblastoma) 9.8 Moderate expression
HEK293 (embryonic kidney) 0.2 Low/background
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1493G>A (p.Arg498His) Missense Rare Impaired choline transport; associated with CMS20
c.914T>C (p.Leu305Pro) Missense Rare Reduced cell surface expression; CMS20
c.1072C>T (p.Arg358*) Nonsense Rare Premature truncation; loss of function; DSMA3
c.1513C>T (p.Arg505Cys) Missense Rare Dominant negative effect; CMS20
Mutation functional classification

Loss of Function (LOF)

Most CMS20 and DSMA3 mutations reduce choline transport activity or protein stability, leading to decreased acetylcholine synthesis.

Gain of Function (GOF)

No gain-of-function mutations have been reported for SLC5A7.

Dominant Negative (DN)

Some missense mutations (e.g., p.Arg505Cys) exert dominant-negative effects by interfering with oligomerization or trafficking of wild-type CHT1.

Gene Ontology (GO)

• extracellular ligand-gated ion channel activity (GO:0005230) high-affinity choline transmembrane transporter activity (GO:0005326)
choline transport (GO:0015871) plasma membrane (GO:0005886)
axon (GO:0030424) synapse (GO:0045202)

Pathways

Acetylcholine synthesis (Reactome: R-HSA-264642)
Neurotransmitter uptake and metabolism (KEGG: hsa04724)
Cholinergic synapse (KEGG: hsa04725)

Protein Summary

The SLC5A7 protein (CHT1) is a 580-amino-acid transmembrane transporter with 13 predicted transmembrane domains. It functions as a homooligomer and is localized to presynaptic cholinergic nerve terminals. CHT1 couples choline import to the sodium and chloride electrochemical gradients. Its expression is tightly regulated by cholinergic activity and is essential for sustaining acetylcholine release. Structural studies reveal a LeuT-fold architecture typical of the SLC5 family.

Related Products

Product name Cat.No. Species Gene ID
SLC5A7 Knockout HEK293 Cell Line EDJ-KQ3767 Human 60482 Details Get a Quote
SLC5A7 Knockout HeLa Cell Line EDJ-KQ56978 Human 60482 Details Get a Quote
SLC5A7 Knockout A-549 Cell Line EDJ-KQ65480 Human 60482 Details Get a Quote
SLC5A7 Knockout HCT 116 Cell Line EDJ-KQ73919 Human 60482 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: